Search

Search Constraints

You searched for: Author/Creator Collard, Olivier

Search Results

1. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme. (September 2019)

2. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial. Issue 8 (August 2022)

3. Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study. Issue 1 (January 2019)

4. Efficacy and safety of regorafenib in patients with metastatic or locally advanced chondrosarcoma: Results of a non-comparative, randomised, double-blind, placebo controlled, multicentre phase II study. (June 2021)

5. Ketamine in chronic pain: A Delphi survey. (8th February 2022)

6. Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms. Issue 1 (9th May 2016)

7. Radiotherapy for gynecologic cancer in nonagenarian patients: a framework for new paradigms. Issue 1 (December 2016)

8. Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting. (April 2016)

9. Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19). (December 2020)

10. Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 12 (December 2016)